Literature DB >> 6951819

The prognosis in osteosarcoma.

S E Larsson, R Lorentzon, H Wedren, L Boquist.   

Abstract

Multifactorial analysis of patients with osteosarcoma of the distal femur and proximal tibia, recorded in the Swedish Cancer Registry during 1958 through 1968, disclosed a 5-year survival of 15.1% for femoral osteosarcomas and 38.1% for tibial tumours. The prognosis was better in adults than in children and better in males than in females. Tumour size, soft tissue involvement, the presence of pathological fracture and the duration of symptoms before treatment influenced the prognosis. The best treatment for the tibial lesions was high amputation alone, whilst for the femoral tumours primary ablative surgery was not superior to combined high-dose radiotherapy and delayed amputation. The main cause for the higher survival rate for tibial neoplasms seemed to be the fact that they were less advanced on admission than those of the distal femur. The findings emphasize the importance of early diagnosis and treatment for improved survival.

Entities:  

Mesh:

Year:  1981        PMID: 6951819     DOI: 10.1007/bf00271087

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  17 in total

1.  Multidrug chemotherapy in pulmonary treatment of osteosarcoma.

Authors:  W W Sutow; E A Gehan; T J Vietti; A E Frias; P G Dyment
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

2.  A follow up study of osteogenic sarcoma.

Authors:  S CEDERLOF; T HIERTONN; E SALEN
Journal:  Acta Orthop Scand       Date:  1960

3.  Osteogenic sarcoma; a study based on 133 patients.

Authors:  S CADE
Journal:  J R Coll Surg Edinb       Date:  1955-12

Review 4.  Multidrug chemotherapy in primary treatment of osteosarcoma. An editorial commentary.

Authors:  N Jaffe; H G Watts
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

5.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

Authors:  N Jaffe; E Frei; D Traggis; Y Bishop
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

6.  Amputation and adriamycin in primary osteosarcoma.

Authors:  E P Cortes; J F Holland; J J Wang; L F Sinks; J Blom; H Senn; A Bank; O Glidewell
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

Review 7.  Prognosis in osteogenic sarcoma.

Authors:  M D Lockshin; I T Higgins
Journal:  Clin Orthop Relat Res       Date:  1968 May-Jun       Impact factor: 4.176

8.  On the natural history of osteosarcoma. Aspects of diagnosis, prognosis and endocrinology.

Authors:  L A Broström
Journal:  Acta Orthop Scand Suppl       Date:  1980

9.  Osteosarcoma: Advances in treatment or changing natural history?

Authors: 
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  The treatment of pulmonary metastasis in osteogenic sarcoma.

Authors:  R C Marcove; N Martini; G Rosen
Journal:  Clin Orthop Relat Res       Date:  1975-09       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.